Change in serum procalcitonin (PCT) predicts the clinical outcome of children admitted with febrile neutropenia

被引:13
作者
Barnes, C
Ignjatovic, V
Newall, F
Carlin, J
Ng, F
Hamilton, S
Ashley, D
Waters, K
Monagle, P
机构
[1] Royal Childrens Hosp, Dept Haematol, Parkville, Vic 3052, Australia
[2] Royal Childrens Hosp, Clin Epidemiol & Biostat Unit, Parkville, Vic 3052, Australia
[3] Royal Childrens Hosp, Dept Haematol & Oncol, Parkville, Vic 3052, Australia
[4] Murdoch Childrens Res Inst, Melbourne, Vic, Australia
[5] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia
关键词
febrile; neutropenia; procalcitonin; paediatric; oncology;
D O I
10.1046/j.1365-2141.2002.37029.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1197 / 1198
页数:2
相关论文
共 8 条
[1]  
ASSCICOT M, 1993, LANCET, V341, P515
[2]   Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults [J].
Bernard, L ;
Ferrière, F ;
Casassus, P ;
Malas, F ;
Lévêque, S ;
Guillevin, L ;
Lortholary, O .
CLINICAL INFECTIOUS DISEASES, 1998, 27 (04) :914-915
[3]   Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II [J].
Fleischhack, G ;
Kambeck, I ;
Cipic, D ;
Hasan, C ;
Bode, U .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (04) :1093-1102
[4]   FEASIBILITY OF OUTPATIENT MANAGEMENT OF FEVER IN CANCER-PATIENTS WITH LOW-RISK NEUTROPENIA - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL [J].
MALIK, IA ;
KHAN, WA ;
KARIM, M ;
AZIZ, Z ;
KHAN, MA .
AMERICAN JOURNAL OF MEDICINE, 1995, 98 (03) :224-231
[5]   Which children with fever and neutropenia can be safely treated as outpatients? [J].
Mullen, CA .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (04) :832-837
[6]   A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia [J].
Mustafa, MM ;
Aquino, VM ;
Pappo, A ;
Tkaczewski, I ;
Buchanan, GR .
JOURNAL OF PEDIATRICS, 1996, 128 (06) :847-849
[7]   Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis [J].
Nylen, ES ;
Whang, KT ;
Snider, RH ;
Steinwald, PM ;
White, JC ;
Becker, KL .
CRITICAL CARE MEDICINE, 1998, 26 (06) :1001-1006
[8]   THE MEDICAL COURSE OF CANCER-PATIENTS WITH FEVER AND NEUTROPENIA - CLINICAL-IDENTIFICATION OF A LOW-RISK SUBGROUP AT PRESENTATION [J].
TALCOTT, JA ;
FINBERG, R ;
MAYER, RJ ;
GOLDMAN, L .
ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (12) :2561-2568